Pharmacokinetic/pharmacodynamic differentiation of pancreatic responsiveness in obese and lean children

Area of Science:

• Pediatric Endocrinology
• Metabolic Physiology
• Pharmacometrics

Background:

• Obesity in children is associated with altered glucose metabolism and insulin secretion.
• Existing models may not fully capture the nuances of beta-cell response to glucose in pediatric obesity.
• Understanding these differences is crucial for metabolic health assessment.

Purpose of the Study:

• To assess the feasibility of a novel PK/PD model for differentiating insulin response in lean versus obese children.
• To investigate beta-cell function using a model that incorporates insulin-glucose physiology.
• To identify specific kinetic parameters indicative of obesity-related metabolic changes.

Main Methods:

• Analysis of glucose and insulin concentrations from blood samples after intravenous glucose administration.
• Application of a new PK/PD model to characterize insulin secretion phases.
• Comparison of model parameters between a group of obese children and a group of lean children.

Main Results:

• The PK/PD model successfully differentiated first and second-phase insulin secretion between obese and lean children (p < 0.05).
• Obese children exhibited a significantly higher proinsulin formation rate constant compared to lean children.
• The model demonstrated good data agreement for both groups, with high correlation coefficients (r = 0.962 for obese, r = 0.980 for lean).

Conclusions:

• The developed PK/PD model is effective in distinguishing between lean and obese prepubertal children.
• Specific kinetic parameters derived from the model reflect differences in beta-cell function related to obesity.
• This model offers a valuable tool for assessing beta-cell responsiveness in pediatric metabolic studies.